[1]
A. Ollech, “Cutaneous Adverse Events to Targeted Therapies and Immuno­therapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres”, Acta Derm Venereol, vol. 101, no. 7, p. adv00501, Jul. 2021.